- GotoDoctor has been selected as Melanoma Canada’s exclusive national Primary Care access partner, connecting Canadians with physician services and strengthening follow-up care through the Mole Mobile skin cancer screening initiative.
- The partnership will combine GotoDoctor’s network of 100+ physicians and providers, AI-enabled care matching, and virtual and in-person services to help patients navigate appropriate care after community-based screening.
- Since launching in 2023, the Mole Mobile has screened 22,483 Canadians across all 10 provinces and identified more than 3,184 suspicious lesions, highlighting the importance of accessible screening and timely follow-up.
- As the Mole Mobile prepares to visit Quebec, the partnership aims to bridge gaps between early detection and clinical care, particularly for Canadians facing barriers to primary care access.
Takeaways:
The partnership strengthens the role of digital health platforms in improving access to primary care and connecting early cancer detection with timely clinical follow-up. It creates growth opportunities for GotoDoctor by expanding its national healthcare reach and demonstrating the value of AI-enabled care navigation. The collaboration also highlights increasing demand for integrated screening and referral models that address gaps in primary care access and support earlier intervention in skin cancer.
Source: Businesswire
